過敏性腸症候群（IBS）の世界市場 2020年

• 英文タイトル：Global Irritable Bowel Syndrome (IBS) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115727 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、過敏性腸症候群（IBS）の世界市場を調査対象にし、過敏性腸症候群（IBS）の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（IBS-D薬、IBS-C薬、その他）、用途別分析（女性、男性）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Allergan、IM HealthScience、Sucampo Pharmaceuticals、Bausch Health、Astellas Pharmaceuticals、Takeda、Sebela Pharmaceuticals、McNeil Consumer Healthcare ・企業別売上、市場シェア ・過敏性腸症候群（IBS）の地域別市場分析 ・過敏性腸症候群（IBS）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・過敏性腸症候群（IBS）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・過敏性腸症候群（IBS）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・過敏性腸症候群（IBS）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・過敏性腸症候群（IBS）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・過敏性腸症候群（IBS）の種類別市場規模2015-2020：IBS-D薬、IBS-C薬、その他 ・過敏性腸症候群（IBS）の用途別市場規模2015-2020：女性、男性 ・過敏性腸症候群（IBS）の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The Irritable Bowel Syndrome (IBS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Irritable Bowel Syndrome (IBS) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 15.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 6545.9 million by 2025, from USD 3702.3 million in 2019.

Market segmentation
Irritable Bowel Syndrome (IBS) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Irritable Bowel Syndrome (IBS) market has been segmented into:
IBS-D Drug
IBS-C Drug
Other

By Application, Irritable Bowel Syndrome (IBS) has been segmented into:
Women
Men

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Irritable Bowel Syndrome (IBS) market presented in the report. This section sheds light on the sales growth of different regional and country-level Irritable Bowel Syndrome (IBS) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Irritable Bowel Syndrome (IBS) market.

The report offers in-depth assessment of the growth and other aspects of the Irritable Bowel Syndrome (IBS) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Irritable Bowel Syndrome (IBS) Market Share Analysis
Irritable Bowel Syndrome (IBS) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Irritable Bowel Syndrome (IBS) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Irritable Bowel Syndrome (IBS) sales, revenue and market share for each player covered in this report.

The major players covered in Irritable Bowel Syndrome (IBS) are:
Allergan
IM HealthScience
Sucampo Pharmaceuticals
Bausch Health
Astellas Pharmaceuticals
Takeda
Sebela Pharmaceuticals
McNeil Consumer Healthcare
Among other players domestic and global, Irritable Bowel Syndrome (IBS) market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Irritable Bowel Syndrome (IBS) Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome (IBS)
1.2 Classification of Irritable Bowel Syndrome (IBS) by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type in 2019
1.2.3 IBS-D Drug
1.2.4 IBS-C Drug
1.2.5 Other
1.3 Global Irritable Bowel Syndrome (IBS) Market by Application
1.3.1 Overview: Global Irritable Bowel Syndrome (IBS) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Women
1.3.3 Men
1.4 Global Irritable Bowel Syndrome (IBS) Market by Regions
1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Irritable Bowel Syndrome (IBS) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Irritable Bowel Syndrome (IBS) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Irritable Bowel Syndrome (IBS) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Irritable Bowel Syndrome (IBS) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Irritable Bowel Syndrome (IBS) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Irritable Bowel Syndrome (IBS) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
2.2 IM HealthScience
2.2.1 IM HealthScience Details
2.2.2 IM HealthScience Major Business
2.2.3 IM HealthScience SWOT Analysis
2.2.4 IM HealthScience Product and Services
2.2.5 IM HealthScience Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sucampo Pharmaceuticals
2.3.1 Sucampo Pharmaceuticals Details
2.3.2 Sucampo Pharmaceuticals Major Business
2.3.3 Sucampo Pharmaceuticals SWOT Analysis
2.3.4 Sucampo Pharmaceuticals Product and Services
2.3.5 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bausch Health
2.4.1 Bausch Health Details
2.4.2 Bausch Health Major Business
2.4.3 Bausch Health SWOT Analysis
2.4.4 Bausch Health Product and Services
2.4.5 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Astellas Pharmaceuticals
2.5.1 Astellas Pharmaceuticals Details
2.5.2 Astellas Pharmaceuticals Major Business
2.5.3 Astellas Pharmaceuticals SWOT Analysis
2.5.4 Astellas Pharmaceuticals Product and Services
2.5.5 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business
2.6.3 Takeda Product and Services
2.6.4 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sebela Pharmaceuticals
2.7.1 Sebela Pharmaceuticals Details
2.7.2 Sebela Pharmaceuticals Major Business
2.7.3 Sebela Pharmaceuticals Product and Services
2.7.4 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
2.8 McNeil Consumer Healthcare
2.8.1 McNeil Consumer Healthcare Details
2.8.2 McNeil Consumer Healthcare Major Business
2.8.3 McNeil Consumer Healthcare Product and Services
2.8.4 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Irritable Bowel Syndrome (IBS) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Irritable Bowel Syndrome (IBS) Players Market Share
3.2.2 Top 10 Irritable Bowel Syndrome (IBS) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions
4.2 North America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
4.3 Europe Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
4.5 South America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
5 North America Irritable Bowel Syndrome (IBS) Revenue by Countries
5.1 North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
5.2 USA Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
5.3 Canada Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
5.4 Mexico Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
6 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries
6.1 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
6.2 Germany Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
6.3 UK Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
6.4 France Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
6.5 Russia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
6.6 Italy Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries
7.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
7.2 China Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
7.3 Japan Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
7.4 Korea Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
7.5 India Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
8 South America Irritable Bowel Syndrome (IBS) Revenue by Countries
8.1 South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
8.2 Brazil Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
8.3 Argentina Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Irritable Bowel Syndrome (IBS) by Countries
9.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
9.3 UAE Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
9.4 Egypt Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
9.5 South Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2015-2020)
10.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Type (2019-2024)
10.3 IBS-D Drug Revenue Growth Rate (2015-2025)
10.4 IBS-C Drug Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Irritable Bowel Syndrome (IBS) Market Segment by Application
11.1 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2015-2020)
11.2 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2019-2024)
11.3 Women Revenue Growth (2015-2020)
11.4 Men Revenue Growth (2015-2020)
12 Global Irritable Bowel Syndrome (IBS) Market Size Forecast (2021-2025)
12.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast (2021-2025)
12.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2021-2025)
12.3 North America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
12.4 Europe Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
12.6 South America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Irritable Bowel Syndrome (IBS) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Irritable Bowel Syndrome (IBS) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Irritable Bowel Syndrome (IBS) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Irritable Bowel Syndrome (IBS) Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Allergan Corporate Information, Location and Competitors
Table 7. Allergan Irritable Bowel Syndrome (IBS) Major Business
Table 8. Allergan Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2017-2018)
Table 9. Allergan SWOT Analysis
Table 10. Allergan Irritable Bowel Syndrome (IBS) Product and Solutions
Table 11. Allergan Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. IM HealthScience Corporate Information, Location and Competitors
Table 13. IM HealthScience Irritable Bowel Syndrome (IBS) Major Business
Table 14. IM HealthScience Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2018-2019)
Table 15. IM HealthScience SWOT Analysis
Table 16. IM HealthScience Irritable Bowel Syndrome (IBS) Product and Solutions
Table 17. IM HealthScience Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sucampo Pharmaceuticals Corporate Information, Location and Competitors
Table 19. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Major Business
Table 20. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2017-2018)
Table 21. Sucampo Pharmaceuticals SWOT Analysis
Table 22. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Solutions
Table 23. Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bausch Health Corporate Information, Location and Competitors
Table 25. Bausch Health Irritable Bowel Syndrome (IBS) Major Business
Table 26. Bausch Health Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2017-2018)
Table 27. Bausch Health SWOT Analysis
Table 28. Bausch Health Irritable Bowel Syndrome (IBS) Product and Solutions
Table 29. Bausch Health Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Astellas Pharmaceuticals Corporate Information, Location and Competitors
Table 31. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Major Business
Table 32. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2017-2018)
Table 33. Astellas Pharmaceuticals SWOT Analysis
Table 34. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Solutions
Table 35. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Takeda Corporate Information, Location and Competitors
Table 37. Takeda Irritable Bowel Syndrome (IBS) Major Business
Table 38. Takeda Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2017-2018)
Table 39. Takeda SWOT Analysis
Table 40. Takeda Irritable Bowel Syndrome (IBS) Product and Solutions
Table 41. Takeda Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Sebela Pharmaceuticals Corporate Information, Location and Competitors
Table 43. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Major Business
Table 44. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2017-2018)
Table 45. Sebela Pharmaceuticals SWOT Analysis
Table 46. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Solutions
Table 47. Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. McNeil Consumer Healthcare Corporate Information, Location and Competitors
Table 49. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Major Business
Table 50. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Total Revenue (USD Million) (2017-2018)
Table 51. McNeil Consumer Healthcare SWOT Analysis
Table 52. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product and Solutions
Table 53. McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Players (2015-2020)
Table 55. Global Irritable Bowel Syndrome (IBS) Revenue Share by Players (2015-2020)
Table 56. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions (2015-2020)
Table 58. North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
Table 59. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Table 60. Europe Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
Table 63. South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Table 66. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) by Type (2015-2020)
Table 67. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2015-2020)
Table 68. Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Type (2021-2025)
Table 69. Global Irritable Bowel Syndrome (IBS) Revenue by Application (2015-2020)
Table 70. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2015-2020)
Table 71. Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Application (2021-2025)
Table 72. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type in 2019
Figure 3. IBS-D Drug Picture
Figure 4. IBS-C Drug Picture
Figure 5. Other Picture
Figure 6. Irritable Bowel Syndrome (IBS) Revenue Market Share by Application in 2019
Figure 7. Women Picture
Figure 8. Men Picture
Figure 9. Global Irritable Bowel Syndrome (IBS) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Irritable Bowel Syndrome (IBS) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Irritable Bowel Syndrome (IBS) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Irritable Bowel Syndrome (IBS) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2018
Figure 23. North America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 26. South America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 28. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2019
Figure 30. USA Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2019
Figure 35. Germany Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 36. UK Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 37. France Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2019
Figure 42. China Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 45. India Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 47. South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2019
Figure 49. Brazil Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2020)
Figure 57. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2015-2020)
Figure 58. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type in 2019
Figure 59. Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2021-2025)
Figure 60. Global IBS-D Drug Revenue Growth Rate (2015-2020)
Figure 61. Global IBS-C Drug Revenue Growth Rate (2015-2020)
Figure 62. Global Other Revenue Growth Rate (2015-2020)
Figure 63. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2015-2020)
Figure 64. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application in 2019
Figure 65. Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2021-2025)
Figure 66. Global Women Revenue Growth Rate (2015-2020)
Figure 67. Global Men Revenue Growth Rate (2015-2020)
Figure 68. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Irritable Bowel Syndrome (IBS) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Irritable Bowel Syndrome (IBS) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
Figure 72. Europe Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
Figure 74. South America Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---